0819 GMT - China Life Insurance's new business value growth in the nine months ended September remains a key bright spot despite the insurer's net profit missing estimates, says DBS Group Research's Ken Shih in a note. The insurer's new business value managed to maintain solid growth of around 13% on year despite the overall industry's decline, the analyst notes. The company is confident in its 2027 new business value growth outlook, citing the bancassurance channel's potential mid-to-long-term growth, he adds. Still, DBS cuts its 2026-2027 earnings projections by 20%-34% after the lower-than-expected net profit. The bank therefore trims its target price to 36.50 Hong Kong dollars from HK$38.00 but maintains a buy rating. Shares closed 3.85% higher at HK$24.80.
Comments